VIVS Q3 2025 Earnings EPS Surprise Beats Estimates Amid Unreported Revenue PRVA Q1 2026 Earnings EPS Miss Puts Focus on Cost Management and Growth Trajectory Credicorp BAP Q4 2025 Earnings EPS Misses Estimates Stock Declines on Profitability Pressure Olema Pharmaceuticals Inc OLMA Q1 2026 Earnings NarrowerThanExpected Loss Amid Ongoing Clinical Progress DOUG Q4 2025 Earnings Massive EPS Miss Sends Stock Lower OSBC Q1 2026 Earnings Earnings Miss but Stable Share Price